# Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

> **NCT00572013** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 32 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Rituxan
- **DRUG:** BEAM
- **PROCEDURE:** Autologous stem cell transplant

## Key facts

- **NCT ID:** NCT00572013
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05-12
- **Primary completion:** 2001-01-01
- **Final completion:** 2009-09-18
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572013, "Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00572013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*